~~<i id='DA262C0150'><strike id='DA262C0150'><tt id='DA262C0150'><pre id='DA262C0150'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：knowledge 2025-09-27 13:03:15 - browse：7

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Protect nursing home residents from future pandemics

focus

hotspot

focus

explore

hotspot

JeffChiu/APAnewfederallawsuitchallengingtheBidenadministration’snewminimumnursinghomestaffingrulelay

WSS

Decentralized clinical trials need collaboration to achieve wider use

Florida Supreme Court upholds state's abortion ban

Trial using CRISPR to edit HIV out of cells disappoints

Why we need mandatory labeling of GMO products

Beyond aggravation: Constipation is an American epidemic

Young boy dies in trial for Pfizer Duchenne gene therapy

entertainment

entertainment

focus

How one medical school became remarkably diverse

Gut bacteria may contribute to kidney autoimmunity, study finds

Dobbs anniversary: the lost opportunity of abortion as health care

Mass General Brigham physicians react to latest merger step

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Alzheimer's risk factor APOE4 may be a distinct form of the disease

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Covid silver lining: Unprecedented look at human immune system

hotspot

Guardant Health colon cancer test endorsed by FDA advisory panel

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Beyond aggravation: Constipation is an American epidemic

Young boy dies in trial for Pfizer Duchenne gene therapy

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Alzheimer's risk factor APOE4 may be a distinct form of the disease

hotspot

focus

explore

hotspot